Scholar's profile
Wu, Shufen
Wu, Shufen
Professor
Department of Biomedical Sciences

Scopus Data (view scopus profile)

Publication Achievements 2003 - 2025
Publication Index
Documents
51
CITATIONS
971
H-INDEX
19
FWCI
0.70
Co-authors
230
Last Sync Date: 2025-08-17

Google Scolar

ORCID

Research output per year
2003
2025
Article
Letter
A total of 51 data records, Page 1 / 6 , records per page, Go to page  
1 2 3 4 5 6

Publication

Print-friendly
  • 1 A human oral commensal-mediatedprotection against Sjögren’s syndromewith maintenance of T cell immunehomeostasis and improved oralmicrobiota
    Yu-Chao Tseng1,2,3, Kai-Sheng Liao4, Wei-ting Lin5, Chin Li3, Chia-Bin Chang6, Jie-Wei Hsu3, Chin-Pui Chan3, Chun-Ming Chen1, Hon-Pin Wang1, Hsiu-Chuan Chien7, Jann-Tay Wang8, Song-Chou Hsieh8 & Shu-FenWu3,9
    npj | biofilms and microbiomes 2025 / 0
    Journal Article
  • 2  Haemophilus parainfluenzae as a potential postbiotic in Sjogren'ssyndrome- a pilot study
    1. Yu-Chao Tseng, Shu-Fen Wu.
    Microbiome 2025 / 3
    Seminar Paper
  • 3 Increased Apolipoprotein A1 Expression Correlates withTumor-Associated Neutrophils and T Lymphocytes in UpperTract Urothelial Carcinoma
    Chih-Chia Chang 1,†, Chia-Bin Chang 2,†, Chiung-Ju Chen 3,4, Chun-Liang Tung 5, Chi-Feng Hung 2, Wei-Hong Lai 2, Cheng-Huang Shen 2,6 , Chang-Yu Tsai 2, Ya-Yan Lai 7, Ming-Yang Lee 8,* , Shu-Fen Wu 9 and Pi-Che Chen
    Curr. Issues Mol. Biol 2024 / 3
    Journal Article
  • 4 Olaparib enhancing radiosensitizationand anti-metastatic effect of oral cancerby targeting IL-17A signal
    Chih-Chia Yu1,2, Hon-Yi Lin2,3, Michael W.Y. Chan4,5,6,7, Shu-Fen Wu4, Wen-Yen Chiou2,3, Moon-Sing Lee2,3, Chen-Lin Chi8, Ru-Inn Lin2, Feng-Chun Hsu2, Hsuan-Ju Yang2, Liang-Cheng Chen2,3, Chia-Hui Chew2,3 and Shih-Kai Hung2,3*
    Cancer Cell International 2024 / 0
    Journal Article
  • 5 Reduced oral Haemophilus parainfluenzae in Sjögren's syndrome prompts dysregulated T cell response through altered salivary gland epithelial cells
    1. Yu-Chao Tseng, Shu-Fen Wu.
    EULAR 2024 – Annual European Congress of Rheumatology 2024 / 6
    Seminar Paper
  • 6 Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling,Leads to Tumor Progression ThroughOverexpression of YWHAZin Gastric Cancer
    Kuo-Liang We、Jian-Liang Chou、Yin-Chen Chen、Jie-Ting Low、Guan-Ling Lin、Jing-Lan Liu、Te-Sheng Chang、Wei-Ming Chen、Yung-Yu Hsieh、Pearlly S. Yan、Yu-Ming Chuang、Jora M. J. Lin、Shu-Fen Wu、Ming-Ko Chiang、Chin Li、Cheng-Shyong Wu、Michael W. Y. Chan
    Frontiers in Oncology 2021 / 2
    Journal Article
  • 7 Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model
    Shih-Han Chen、Jui-Ming Sun、Bing-Mao Chen、Sheng-Che Lin、Hao-Fang Chang、Sara Collins、Deching Chang、Shu-Fen Wu、Yin-Che Lu、Weijun Wang、Thomas C Chen、Noriyuki Kasahara、Hsin-Ell Wang、Chien-Kuo Tai
    International Journal of Molecular Sciences 2020 / 2
    Journal Article
  • 8  Altered surface molecular expression for antigen-presentation on salivary gland epithelial cell line, implication on pathogenesis and therapeutics of salivary microbiota in primary Sjögren’s syndrome. 
    2. Yu-Chao Tseng, Shu-Fen Wu.
    Microbiome: Therapeutic Implications. 2019 / 10
    Seminar Paper
  • 9 Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling
    Shu-Fen Wu, Chia-Bin Chang, Jui-Mei Hsu, Ming-Chi Lu, Ning-Sheng Lai, Chin Li and Chien-Hsueh Tung
    Arthritis Research & Therapy 2017 / 8
    Journal Article
  • 10 Guizhi Fuling Wan as a novel agent for intravesical treatment for bladder cancer in mouse model.
    Chi-Chen Lu,, Cheng-Huang Shen,, Chia-Bin Chang,, Hsiao-Yen Hsieh,, Jiann-Der Wu, Ling-Huei Tseng,, Dennis W. Hwang, Syue-Yi Chen,, Shu-Fen Wu*, Michael WY Chan* and Cheng-Da Hsu
    Molecular Medicine 2016 / 2
    Journal Article
1 2 3

Projects

Print-friendly
Teacher's name Research Units Year Project title Project position Commissioning unit Implementation period
Wu, Shufen Department of Biomedical Sciences 2026 SYTL3在逆轉泌尿道上皮癌腫瘤免疫逃避作用的研究(3/3) Co-PI 國家科學及技術委員會 2026/08/01-2027/07/31
Wu, Shufen Department of Biomedical Sciences 2025 SYTL3在逆轉泌尿道上皮癌腫瘤免疫逃避作用的研究(2/3) Co-PI 國家科學及技術委員會 2025/08/01-2027/07/31
Wu, Shufen Department of Biomedical Sciences 2024 探討副流感嗜血桿菌誘導的先天免疫耐受性及其作用機制 PI 國家科學及技術委員會 2024/08/01-2025/07/31
Wu, Shufen Department of Biomedical Sciences 2024 SYTL3在逆轉泌尿道上皮癌腫瘤免疫逃避作用的研究(1/3) Co-PI 國家科學及技術委員會 2024/08/01-2027/07/31
Wu, Shufen Department of Biomedical Sciences 2023 細胞激素誘導之殺手細胞及自然殺手細胞之擴增 PI 通用幹細胞股份有限公司 2023/01/01-2023/12/31
Wu, Shufen Department of Biomedical Sciences 2023 佩你安透過抑制脂質代謝恢復泌尿道上皮癌抗腫瘤免疫反應之研究(3/3) Co-PI 國科會 2023/08/01-2024/07/31
Wu, Shufen Department of Biomedical Sciences 2023 口腔常在菌-副流感嗜血桿菌在自體免疫疾病的調控及其機制 PI 國家科學及技術委員會 2023/08/01-2024/07/31
Wu, Shufen Department of Biomedical Sciences 2023 利用小鼠評估中和抗體對JC類病毒疫苗的影響 PI 思凱生科有限公司 2023/03/01-2024/12/31
Wu, Shufen Department of Biomedical Sciences 2022 跨領域醫療議題(二)-探討口腔副流感嗜血桿菌在修格蘭氏症中調控抗原呈現細胞的角色 PI 戴德森醫療財團法人嘉義基督教醫院 2022/01/01-2022/12/31
Wu, Shufen Department of Biomedical Sciences 2022 JC病毒樣顆粒疫苗對小鼠的免疫原性 PI 思凱生科有限公司 2022/01/01-2022/12/31
Wu, Shufen Department of Biomedical Sciences 2022 佩你安透過抑制脂質代謝恢復泌尿道上皮癌抗腫瘤免疫反應之研究(2/3) Co-PI 國科會 2022/08/01-2024/07/31
Wu, Shufen Department of Biomedical Sciences 2021 佩你安透過抑制脂質代謝恢復泌尿道上皮癌抗腫瘤免疫反應之研究(1/3) Co-PI 國科會 2021/08/01-2024/07/31
Wu, Shufen Department of Biomedical Sciences 2020 佩你安於泌尿道上皮癌作為表觀遺傳修飾藥物以增加免疫治療之研究(2/2) Co-PI 國科會 2020/08/01-2021/07/31
Wu, Shufen Department of Biomedical Sciences 2019 佩你安於泌尿道上皮癌作為表觀遺傳修飾藥物以增加免疫治療之研究(1/2) Co-PI 國科會 2019/08/01-2021/07/31
Wu, Shufen Department of Biomedical Sciences 2018 探討DNA低甲基化造成TH17細胞抑制之機制以及在自體免疫疾病之應用 PI 國科會 2018/08/01-2019/07/31
Wu, Shufen Department of Biomedical Sciences 2018 對外專業技術服務-免疫細胞檢測及分析 PI 芮生生醫股份有限公司 2018/04/01-2019/03/31
Wu, Shufen Department of Biomedical Sciences 2018 高齡醫療議題研究 Co-PI 戴德森醫療財團法人嘉義基督教醫院 2018/12/03-2020/06/30
Wu, Shufen Department of Biomedical Sciences 2018 南科投資設立審查案--基可生醫股份有限公司 Co-PI 南部科學工業園區管理局 2018/09/03-2018/10/03
Wu, Shufen Department of Biomedical Sciences 2018 RCN010-探討高齡的人自體免疫乾燥症病人微生物相與免疫系統的交互作用 PI 戴德森醫療財團法人嘉義基督教醫院 2018/12/03-2020/06/30
Wu, Shufen Department of Biomedical Sciences 2017 106大專生計畫-探討去甲基化藥物(5-Aza-2'-deoxycytidine)對功能性T細胞分化的影響 PI 國科會 2017/07/01-2018/02/28
Wu, Shufen Department of Biomedical Sciences 2015 探討去甲基化藥物(5-Aza-2'-deoxycytidine)在實驗性自體免疫腦脊髓炎小鼠的保護機制 PI 國科會 2015/08/01-2016/07/31
Wu, Shufen Department of Biomedical Sciences 2015 miR-193a 之雙重表基因調控及其在卵巢癌之臨床應用研究 Co-PI 國科會 2015/08/01-2016/07/31
Wu, Shufen Department of Biomedical Sciences 2014 對外專業技術服務-協助檢體檢測條件之設定及最佳化 PI 順智興業股份有限公司 2014/08/01-2015/07/31
Wu, Shufen Department of Biomedical Sciences 2013 描述SOX2 在轉錄後訊息RNA 調控中所扮演的功能 Co-PI 國科會 2013/08/01-2014/07/31
Wu, Shufen Department of Biomedical Sciences 2013 大專生計畫-以約翰坎寧安類病毒殼體作為基因治療載體攜帶寡樹突細胞轉錄因子進行實驗性自體免疫腦脊髓炎動物模式之髓鞘修復 PI 國科會 2013/07/01-2014/02/28
Wu, Shufen Department of Biomedical Sciences 2013 大專生計畫-探討5-Aza-2’-deoxycytidine處理自體免疫腦脊髓炎小鼠中樹突狀細胞的影響 PI 國科會 2013/07/01-2014/02/28
Wu, Shufen Department of Biomedical Sciences 2013 以實驗性自體免疫腦脊髓膜炎探討去甲基化藥劑 (5-AZA-2-deoxycytidine) 促使Foxp3基因表現及其免疫調控機制 PI 國科會 2013/08/01-2014/07/31
Wu, Shufen Department of Biomedical Sciences 2012 探討Foxo3在自體免疫腦脊髓膜炎對樹突狀細胞的調控及其機制(3/3) PI 國科會 2012/08/01-2013/07/31
Wu, Shufen Department of Biomedical Sciences 2012 AR Based 植牙手術導引 SI 里昂哈佛國際事業股份有限公司 2012/10/01-2015/09/30
Wu, Shufen Department of Biomedical Sciences 2011 探討Foxo3在自體免疫腦脊髓膜炎對樹突狀細胞的調控及其機制(2/3) PI 國科會 2011/08/01-2013/07/31
Wu, Shufen Department of Biomedical Sciences 2010 探討Foxo3在自體免疫腦脊髓膜炎對樹突狀細胞的調控及其機制(1/3) PI 國科會 2010/08/01-2013/07/31
Wu, Shufen Department of Biomedical Sciences 2009 大專生計畫-調控樹突狀細胞分泌細胞激素的功能以抑制自體免疫反應 PI 國科會 2009/07/01-2010/02/28
Wu, Shufen Department of Biomedical Sciences 2009 以實驗性自體免疫腦脊髓膜炎模式探討第三號誘餌受體調控樹突狀細胞之免疫反應及其作用機制(3/3) PI 國科會 2009/08/01-2010/07/31
Wu, Shufen Department of Biomedical Sciences 2009 充實研究設備提升生物科技研究能量-中正大學提昇生命科學研究能力計畫 Co-PI 國科會 2009/12/01-2010/07/31
Wu, Shufen Department of Biomedical Sciences 2008 以實驗性自體免疫腦脊髓膜炎模式探討第三號誘餌受體調控樹突狀細胞之免疫反應及其作用機制(2/3) PI 國科會 2008/08/01-2010/07/31
Wu, Shufen Department of Biomedical Sciences 2007 以實驗性自體免疫腦脊髓膜炎模式探討第三號誘餌受體調控樹突狀細胞之免疫反應及其作用機制(1/3) PI 國科會 2007/08/01-2010/07/31
Wu, Shufen Department of Biomedical Sciences 2007 探討巨噬細胞、支氣管表皮細胞和T細胞彼此間交互作用如何調控奈米碳管所引起的細胞毒性的分子機制 Co-PI 國科會 2007/08/01-2008/09/30
Wu, Shufen Department of Biomedical Sciences 2007 探討MOG誘導之EAE老鼠其Dendritic cell於DcR3處理後IL-23、IL-27 gene表達 PI 國科會 2007/07/01-2008/02/28
Wu, Shufen Department of Biomedical Sciences 2006 以實驗性自體免疫腦脊髓膜炎模式探討調控樹突狀細胞之免疫反應及其作用機制 PI 國科會 2006/12/01-2007/07/31
Source:Chung Cheng Academic Achievements Information System